Alembic Pharmaceuticals Limited — Others, 09-04-2025: Copy of Newspaper Publication

Alembic Pharmaceuticals Limited has announced a board meeting to address a notice regarding the loss of an equity share certificate. The affected shareholder, Kokila M. Jhaveri, alongside Minesh S. Jhaveri, has applied for a duplicate certificate for 930 shares between distinctive numbers 58506312 and 58507241. Stakeholders with claims must submit evidence to the company or its RTA within 15 days of the notice's publication. Failing to do so will lead to the issuance of duplicates without further recourse. This development may prompt investor caution due to potential share discrepancies but also highlights the company’s responsive governance towards shareholder requests, indicating proactive management.